Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

High-level nitrofurantoin resistance in a clinical isolate of Klebsiella pneumoniae: a comparative genomics and metabolomics analysis

Open access

Abstract

Nitrofurantoin is a commonly used chemotherapeutic agent in the treatment of uncomplicated urinary tract infections caused by the problematic multidrug resistant Gram-negative pathogen Klebsiella pneumoniae . The present study aims to elucidate the mechanism of nitrofurantoin action and high-level resistance in K. pneumoniae using whole-genome sequencing (WGS), qPCR analysis, mutation structural modeling and untargeted metabolomic analysis. WGS profiling of evolved highly resistant mutants (nitrofurantoin minimum inhibitory concentrations > 256 mg/L) revealed modified expression of several genes related to membrane transport (porin ompK36 and efflux pump regulator oqxR ) and nitroreductase activity ( ribC and nfsB , involved in nitrofurantoin reduction). Untargeted metabolomics analysis of total metabolites extracted at 1 and 4 h post-nitrofurantoin treatment revealed that exposure to the drug caused a delayed effect on the metabolome which was most pronounced after 4 h. Pathway enrichment analysis illustrated that several complex interrelated metabolic pathways related to nitrofurantoin bacterial killing (aminoacyl-tRNA biosynthesis, purine metabolism, central carbohydrate metabolism, and pantothenate and CoA biosynthesis) and the development of nitrofurantoin resistance (riboflavin metabolism) were significantly perturbed. This study highlights for the first time the key role of efflux pump regulator oqxR in nitrofurantoin resistance and reveals global metabolome perturbations in response to nitrofurantoin, in K. pneumoniae . IMPORTANCE: A quest for novel antibiotics and revitalizing older ones (such as nitrofurantoin) for treatment of difficult-to-treat Gram-negative bacterial infections has become increasingly popular. The precise antibacterial activity of nitrofurantoin is still not fully understood. Furthermore, although the prevalence of nitrofurantoin resistance remains low currently, the drug’s fast-growing consumption worldwide highlights the need to comprehend the emerging resistance mechanisms. Here, we used multidisciplinary techniques to discern the exact mechanism of nitrofurantoin action and high-level resistance in Klebsiella pneumoniae , a common cause of urinary tract infections for which nitrofurantoin is the recommended treatment. We found that the expression of multiple genes related to membrane transport (including active efflux and passive diffusion of drug molecules) and nitroreductase activity was modified in nitrofurantoin-resistant strains, including oqxR, the transcriptional regulator of the oqxAB efflux pump. Furthermore, complex interconnected metabolic pathways that potentially govern the nitrofurantoin-killing mechanisms (e.g., aminoacyl-tRNA biosynthesis) and nitrofurantoin resistance (riboflavin metabolism) were significantly inhibited following nitrofurantoin treatment. Our study could help inform the improvement of nitrofuran derivatives, the development of new pharmacophores, or drug combinations to support the resurgence of nitrofurantoin in the management of multidrug resistant K. pneumouniae infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/msystems.00972-23

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Bar graphs show the differential expression of oqxB, acrA, acrB, ompC, ribC, and nfsB genes in six nitrofurantoin-resistant K. pneumouniae isolates compared with the wild-type isolates K. pneumouniae INF348. The data for each gene were derived from the average of three biological replicates, using the delta-delta Ct method. The grid line in the chart represents the log2FC cut-off of ≥0.59 or ≤−0.59.
Fig 1 Bar graphs show the differential expression of oqxB, acrA, acrB, ompC, ribC, and nfsB genes in six nitrofurantoin-resistant K. pneumouniae isolates compared with the wild-type isolates K. pneumouniae INF348. The data for each gene were derived from the average of three biological replicates, using the delta-delta Ct method. The grid line in the chart represents the log2FC cut-off of ≥0.59 or ≤−0.59.CC BY · PubMed Central
Fig 2 (A) Interaction between amino acid residues and FMN plotted by LigPlot+: amino acid residues identified that are essential for stabilizing FMN of K. pneumouniae NfsB and (B) the mapping of critical mutations D198Y and W46C onto the dimeric structure of the enzyme utilizing a space-filling representation for the residues. NIC = nicotinic acid.
Fig 2 (A) Interaction between amino acid residues and FMN plotted by LigPlot+: amino acid residues identified that are essential for stabilizing FMN of K. pneumouniae NfsB and (B) the mapping of critical mutations D198Y and W46C onto the dimeric structure of the enzyme utilizing a space-filling representation for the residues. NIC = nicotinic acid.CC BY · PubMed Central
Fig 3 Schematic diagram shows the aminoacyl-tRNA biosynthesis and fold changes of significantly impacted metabolites K. pneumoniae INF348 following nitrofurantoin treatment at 1 and 4 h (log2FC ≥ 1.0, P ≤ 0.05). Data are mean ± SD for four biological replicates. The grid line in the chart represents the log2FC cut-off of ≥1 or ≤ −1.
Fig 3 Schematic diagram shows the aminoacyl-tRNA biosynthesis and fold changes of significantly impacted metabolites K. pneumoniae INF348 following nitrofurantoin treatment at 1 and 4 h (log2FC ≥ 1.0, P ≤ 0.05). Data are mean ± SD for four biological replicates. The grid line in the chart represents the log2FC cut-off of ≥1 or ≤ −1.CC BY · PubMed Central
Fig 4 (A) Schematic diagram depicting the significantly impacted purine metabolism of K. pneumoniae INF348 following nitrofurantoin treatment at 4 h. (B) Bar charts for the significantly impacted intermediates from purine metabolism of K. pneumoniae INF348 treated with nitrofurantoin at 1 and 4 h. (log2FC ≥ 1.0, P ≤ 0.05). Data are mean ± SD for four biological replicates. Blue rectangles: significantly decreased metabolites; red rectangles: significantly increased metabolites. The grid line in the chart represents the log2FC cut-off of ≥1 or ≤ −1.
Fig 4 (A) Schematic diagram depicting the significantly impacted purine metabolism of K. pneumoniae INF348 following nitrofurantoin treatment at 4 h. (B) Bar charts for the significantly impacted intermediates from purine metabolism of K. pneumoniae INF348 treated with nitrofurantoin at 1 and 4 h. (log2FC ≥ 1.0, P ≤ 0.05). Data are mean ± SD for four biological replicates. Blue rectangles: significantly decreased metabolites; red rectangles: significantly increased metabolites. The grid line in the chart represents the log2FC cut-off of ≥1 or ≤ −1.CC BY · PubMed Central
Fig 5 (A) Diagram of significantly influenced nicotinate and nicotinamide metabolism of K. pneumoniae INF348 after nitrofurantoin treatment at 4 h. (B) Fold changes for the significantly impacted metabolites from nicotinate and nicotinamide metabolism in K. pneumoniae INF348 treated with nitrofurantoin at 1 and 4 h (log2FC ≥ 1.0, P ≤ 0.05). Data are mean ± SD for four biological replicates. Blue rectangles: significantly decreased metabolites; red rectangles: significantly increased metabolites. The grid line in the chart represents the log2FC cut-off of ≥1 or ≤ −1.
Fig 5 (A) Diagram of significantly influenced nicotinate and nicotinamide metabolism of K. pneumoniae INF348 after nitrofurantoin treatment at 4 h. (B) Fold changes for the significantly impacted metabolites from nicotinate and nicotinamide metabolism in K. pneumoniae INF348 treated with nitrofurantoin at 1 and 4 h (log2FC ≥ 1.0, P ≤ 0.05). Data are mean ± SD for four biological replicates. Blue rectangles: significantly decreased metabolites; red rectangles: significantly increased metabolites. The grid line in the chart represents the log2FC cut-off of ≥1 or ≤ −1.CC BY · PubMed Central
Fig 6 (A) The significantly perturbed riboflavin metabolism of K. pneumoniae INF348 due to nitrofurantoin treatment. (B) Bar charts for the significantly perturbed intermediates from riboflavin metabolism at 1 and 4 h (log2FC ≥ 1.0, P ≤ 0.05). Data are mean ± SD for four biological replicates. Blue rectangles: significantly decreased metabolites; red rectangles: significantly increased metabolites.
Fig 6 (A) The significantly perturbed riboflavin metabolism of K. pneumoniae INF348 due to nitrofurantoin treatment. (B) Bar charts for the significantly perturbed intermediates from riboflavin metabolism at 1 and 4 h (log2FC ≥ 1.0, P ≤ 0.05). Data are mean ± SD for four biological replicates. Blue rectangles: significantly decreased metabolites; red rectangles: significantly increased metabolites.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 5

  1. 10.4103/0255-0857.167350 · DOI
  2. 10.1128/AAC.02156-15 · DOI
  3. 10.1093/jac/33.suppl_a.23 · DOI · Paper page
  4. McCalla DR, Reuvers A, Kaiser C. 1971. Breakage of bacterial DNA by nitrofuran derivatives. Cancer Res 31:2184–2188.
  5. 10.1002/(sici)1097-0134(1997)1+<29::aid-prot5>3.3.co;2-4 · doi:10.1002/(sici)1097-0134(1997)1+<29::aid-prot5>3.3.co;2-4

Cited by

See all 14

Metadata

Authors
Hussein, M., Sun, Z., Hawkey, J., Allobawi, R., Judd, L. M., Carbone, V., Sharma, R., Thombare, V., Baker, M., Rao, G. G., Li, J., Holt, K. E., & Velkov, T.
Affiliations
  • Monash University (AU)
  • The University of Melbourne (AU)
  • AgResearch (NZ)
  • University of North Carolina at Chapel Hill (US)
  • University of Newcastle Australia (AU)
  • London School of Hygiene & Tropical Medicine (GB)
Corresponding author
  • Holt, Kathryn E.
  • Velkov, Tony
Venue
mSystems
Published
2024-01-23
Volume
9
Issue
1
Pages
e0097223-e0097223
ISSN
2379-5077 (ISSN-L)
OpenAlex
W4389558828
Cited by
14
References
59
Citations by year
2026: 8 · 2025: 4 · 2024: 2
FWCI
1.18
Type
journal article
Language
en
Open access
Licence
Locations
  • mSystems (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • NOVA (University of Newcastle Australia) (submittedVersion)
Funders
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI146241)
  • Bill and Melinda Gates Foundation (OPP1175797)
Topics
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Physical Sciences › Environmental Science › Pollution › Pharmaceutical and Antibiotic Environmental Impacts
Keywords
nitrofurantoin resistance, Klebsiella pneumoniae, nitroreductase, NfsB, efflux pump regulation, bacterial metabolome, drug resistance mechanisms, multidrug resistance, urinary tract infection, riboflavin metabolism, purine metabolism, aminoacyl-tRNA biosynthesis, pantothenate and CoA biosynthesis
MeSH terms
Anti-Bacterial Agents, Humans, Klebsiella Infections, Klebsiella pneumoniae, Nitrofurantoin, Nitroreductases, Riboflavin, RNA, Transfer, Urinary Tract Infections, Genomics, Drug Resistance, Multiple, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.